Wells Fargo
COCP icon

Wells Fargo’s Cocrystal Pharma COCP Stock Holding History

Wells Fargo’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57K Sell
6,257
-782
-11% -$962 ﹤0.01% 6171
2026
Q1 		$7.11K Buy
7,039
+6,251
+793% +$6.45K ﹤0.01% 6032
2025
Q4 		$772 Sell
788
-1,024
-57% -$1.08K ﹤0.01% 6303
2025
Q3 		$2.27K Hold
1,812
– – ﹤0.01% 6173
2025
Q2 		$2.7K Buy
1,812
+1,806
+30,100% +$2.69K ﹤0.01% 6175
2025
Q1 		$9 Hold
6
– – ﹤0.01% 6787
2024
Q4 		$12 Buy
+6
New +$12 ﹤0.01% 6792
2024
Q2 		– Sell
-93
Closed -$130 – 6994
2024
Q1 		$130 Buy
93
+1
+1% +$2 ﹤0.01% 6598
2023
Q4 		$159 Buy
92
+3
+3% +$5 ﹤0.01% 6660
2023
Q3 		$166 Sell
89
-12
-12% -$30 ﹤0.01% 6633
2023
Q2 		$241 Buy
101
+15
+17% +$36 ﹤0.01% 6646
2023
Q1 		$172 Buy
86
+1
+1% +$2 ﹤0.01% 6814
2022
Q4 		$166 Buy
85
+1
+1% +$3 ﹤0.01% 6672
2022
Q3 		$0 Sell
84
-1
-1% -$5 ﹤0.01% 6735
2022
Q2 		$0 Buy
85
+5
+6% +$27 ﹤0.01% 6876
2022
Q1 		$0 Hold
80
– – ﹤0.01% 7139
2021
Q4 		$0 Hold
80
– – ﹤0.01% 7277
2021
Q3 		$1K Sell
80
-99
-55% -$1.31K ﹤0.01% 6674
2021
Q2 		$4K Buy
179
+117
+189% +$1.78K ﹤0.01% 6389
2021
Q1 		$1K Hold
62
– – ﹤0.01% 6696
2020
Q4 		$1K Buy
62
+39
+170% +$542 ﹤0.01% 6331
2020
Q3 		$0 Buy
23
+4
+21% +$73 ﹤0.01% 6373
2020
Q2 		$0 Buy
19
+7
+58% +$86 ﹤0.01% 6325
2020
Q1 		$0 Buy
+12
New +$113 ﹤0.01% 6252

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Wells Fargo's COCP Position: Q2 2026 in Review

Wells Fargo reduced its Cocrystal Pharma (COCP) stake by 11% in Q2 2026, selling an estimated $962 and leaving 6,257 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #6171.

Wells Fargo first reported a position in COCP in Q1 2020 and has held it in 24 quarters since. The position peaked at $7.11K in Q1 2026. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Wells Fargo held 6,257 shares of Cocrystal Pharma worth $6.57K as of Q2 2026.
  • Wells Fargo sold 782 Cocrystal Pharma shares in Q2 2026, an estimated $962.
  • Cocrystal Pharma made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6171 holding.
  • Wells Fargo first reported a position in Cocrystal Pharma in Q1 2020 and has held it in 24 quarters since.
  • Wells Fargo's Cocrystal Pharma position peaked at $7.11K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.